Munar PharmaS.A.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2008-01-30
Share capital
4 697 570,00 PLN
Activity description

Munar Pharma S.A. is a joint-stock company based in Warsaw, formerly operating as Munar S.A. and No Gravity Games S.A. The management board has announced an Ordinary General Meeting for 30 June 2026. The company is currently carrying out analytical work on changing its business scope and future direction.

Registered address
Aleje Jerozolimskie 89/43, 02-001 Warszawa, Poland
Website
munar.plWebsite active

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Stock quotes

PLN 0.37
-0.01 (-1.60%)
0.350.360.370.3710:0012:0014:0016:00
Open
PLN 0.38
High
PLN 0.38
Low
PLN 0.35
Volume
9.78K
Avg. vol.
7.28K
Market cap
PLN 17.33M
P/E ratio
—
EPS
-PLN 0.01
Shares outstanding
46.98M
52-week
PLN 0.34 – 0.41
Dividend yield
—
Dividend
—
Ex dividend date
—
ISIN
PLSITE000013
Exchange
NewConnect

Quarterly results

PeriodRevenueEBITNet profit
Q2 2026USD 67.53kUSD -22.69kUSD -22.69k
Q1 2026USD 540.25USD -21.61kUSD -15.67k
Q4 2025USD 16.83kUSD -102.71kUSD -107.99k
Q3 2025USD 53.49kUSD -37.92kUSD -37.92k

Results for Q3 2026:Nov 16, 2026

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 85.65kMedianUSD 816.16kAverageUSD 29.28m
Net profit
This companyUSD -189.84kMedianUSD 8.96kAverageUSD 2.64m
Operating costs
This companyUSD 241.71kMedianUSD 701.47kAverageUSD 19.26m
Assets
This companyUSD 492.78kMedianUSD 800.13kAverageUSD 29.34m

Industry

Bank accounts

Registered as a VAT taxpayer on 2008-01-24. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

MSiG notices

Publication dateEvent
Apr 10, 2025Dissolution without liquidation opened
Feb 10, 2021Commercial Companies Code notice
Mar 1, 2010Merger plan
Feb 2, 2010Commercial Companies Code notice

Public aid

10 public aid cases recorded, with a total value of $19,051.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
—
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
—
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
—

Tenders

No recorded participation in tenders.

Authorized Representatives

Grzegorz Władysław Konrad — President of the Management Board

Manner of representation

In the case of a multi-member management board, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company. In the case of a one-person management board, the sole member of the management board is independently authorized to make declarations on behalf of the company.

Supervisory board

Bartłomiej Krzysztof Twaróg — Supervisory Board Member
Bartosz Kubacki — Supervisory Board Member
Jarosław Grzechulski — Supervisory Board Member
Piotr Jakubowski — Supervisory Board Member
Mariusz Matusiak — Supervisory Board Member

Beneficial owners

No beneficial owners recorded for the company Munar Pharma.

Subsidiaries

NameStake
Cyber Rain Gamessp. z o.o.
12.5%
Squibly Interactivesp. z o.o.
54.8847%

Capital group

NameOwnership
'No Gravity Development S.A
56.41%

Competitors

Name
Zeptor Polskasp. z o.o.
DR Andresp. z o.o.
STEM Cells SpinS.A.
F1 PharmaS.A.
Ti-Comsp. z o.o.
LideoS.A.
Ampliconsp. z o.o.
Xenira Pharmaceuticalssp. z o.o.

Change history

DateEvent
2025-09-16Share capital change
2025-06-23Name change
2025-06-23PKD change
2024-12-24Address change
2024-10-01Share capital change

FAQ

Last updated: 2026-09-01